Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: Possible applications to Alzheimer disease

Hyman, 2012, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease, Alzheimers Dement, 8, 1, 10.1016/j.jalz.2011.10.007 Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009 Choi, 2009, Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain, J Nucl Med, 50, 1887, 10.2967/jnumed.109.065284 Koronyo-Hamaoui, 2011, Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model, Neuroimage, 54, S204, 10.1016/j.neuroimage.2010.06.020 Lee, 2011, Synthesis and evaluation of 1-(4-[(18)F]fluoroethyl)-7-(4′-methyl)curcumin with improved brain permeability for beta-amyloid plaque imaging, Bioorg Med Chem Lett, 21, 5765, 10.1016/j.bmcl.2011.08.003 Ray, 2009, Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin, Curr Opin Pharmacol, 9, 434, 10.1016/j.coph.2009.06.012 Yanagisawa, 2011, In vivo detection of amyloid beta deposition using (1)F magnetic resonance imaging with a (1)F-containing curcumin derivative in a mouse model of Alzheimer's disease, Neuroscience, 184, 120, 10.1016/j.neuroscience.2011.03.071 Costantino, 2009, Chapter 3—colloidal systems for CNS drug delivery, Prog Brain Res, 180, 35, 10.1016/S0079-6123(08)80003-9 Jolck, 2011, Engineering liposomes and nanoparticles for biological targeting, Adv Biochem Eng Biotechnol, 125, 251 Re, 2010, Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide, J Biotechnol, 156, 341, 10.1016/j.jbiotec.2011.06.037 Roney, 2005, Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer's disease, J Control Release, 108, 193, 10.1016/j.jconrel.2005.07.024 Yang, 2010, Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis, Pharm Res, 27, 1759, 10.1007/s11095-010-0141-7 Webb, 2007, Liposomal drug delivery: recent patents and emerging opportunities, Recent Pat Drug Deliv Formul, 1, 185, 10.2174/187221107782331593 Ghaghada, 2010, Liposomal contrast agents in brain tumor imaging, Neuroimaging Clin N Am, 20, 367, 10.1016/j.nic.2010.05.001 Kakinuma, 1996, Drug delivery to the brain using thermosensitive liposome and local hyperthermia, Int J Hyperthermia, 12, 157, 10.3109/02656739609023698 Zhang, 2003, The study on brain targeting of the amphotericin B liposomes, J Drug Target, 11, 117, 10.1080/1061186031000115150 Usta, 2007, Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells, Chem Res Toxicol, 20, 1895, 10.1021/tx7002245 Stewart, 1980, Colorimetric determination of phospholipids with ammonium ferrothiocyanate, Anal Biochem, 104, 10, 10.1016/0003-2697(80)90269-9 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Montine, 2012, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach, Acta Neuropathol, 123, 1, 10.1007/s00401-011-0910-3 1997 Khopde, 2000, Effect of solvent on the excited-state photophysical properties of curcumin, Photochem Photobiol, 72, 625, 10.1562/0031-8655(2000)072<0625:EOSOTE>2.0.CO;2 Kim, 2010, The photo- and electrophysical properties of curcumin in aqueous solution, Spectrochim Acta A Mol Biomol Spectrosc, 76, 384, 10.1016/j.saa.2010.03.032 Mukerjee, 2010, Spectroscopic properties of curcumin: orientation of transition moments, J Phys Chem B, 114, 12679, 10.1021/jp104075f Nardo, 2012, Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin, J Fluoresc, 22, 597, 10.1007/s10895-011-0995-z Zhang, 2010, Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein, J Biol Chem, 285, 28472, 10.1074/jbc.M110.133520 Weibel, 1979 Hardy, 2002, Testing times for the “amyloid cascade hypothesis”, Neurobiol Aging, 23, 1073, 10.1016/S0197-4580(02)00042-8 Orgogozo, 2003, Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization, Neurology, 61, 46, 10.1212/01.WNL.0000073623.84147.A8 Garcia-Alloza, 2007, Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model, J Neurochem, 102, 1095, 10.1111/j.1471-4159.2007.04613.x Ran, 2009, Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits, J Am Chem Soc, 131, 15257, 10.1021/ja9047043 Burgos-Moron, 2010, The dark side of curcumin, Int J Cancer, 126, 1771 Basnet, 2012, Liposomal delivery system enhances anti-inflammatory properties of curcumin, J Pharm Sci, 101, 598, 10.1002/jps.22785 Kunwar, 2006, Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study, Biochim Biophys Acta, 1760, 1513, 10.1016/j.bbagen.2006.06.012 Li, 2005, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis, Cancer, 104, 1322, 10.1002/cncr.21300 Mourtas, 2011, Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1–42 peptide, Biomaterials, 32, 1635, 10.1016/j.biomaterials.2010.10.027 Taylor, 2011, Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Abeta peptide, Nanomedicine, 7, 541, 10.1016/j.nano.2011.06.015 Mancuso, 2011, Curcumin and Alzheimer disease: this marriage is not to be performed, J Biol Chem, 286, le3, 10.1074/jbc.L110.133520